Prokinetic Drug Market Insights, Global Outlook and Forecast 2022-2028
Prokinetic Drug Market Insights, Global Outlook and Forecast 2022-2028
Prokinetic Drug Market by End User (Office Building Construction, Retail Construction, Hospitality Construction, Institutional Construction, Other End Users), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast - is a comprehensive report that provides insights into the market dynamics, including the key drivers, challenges, and opportunities shaping the industry landscape. It also delves into the competitive landscape, highlighting the major players and their strategies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
A prokinetic agent (also gastroprokinetic agent, gastrokinetic agent or propulsive) is a type of drug which enhances gastrointestinal motility by increasing the frequency or strength of contractions, but without disrupting their rhythm. They are used to treat certain gastrointestinal symptoms, including abdominal discomfort, bloating, constipation, heart burn, nausea, and vomiting; and certain gastrointestinal disorders, including irritable bowel syndrome, gastritis, gastroparesis, and functional dyspepsia.
The latest research study released by Market IntelliX evaluates market size and forecasts of Prokinetic Drug in global, including the following market information:
Global Prokinetic Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Prokinetic Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Prokinetic Drug companies in 2021 (%)
The global Prokinetic Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Metoclopramide Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prokinetic Drug include Sumitomo, Johnson & Johnson, Sanofi, Kyowa Kirin Pharmaceuticals, Pfizer, Teva, Cadila Pharmaceuticals and Hanmi Pharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Prokinetic Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Prokinetic Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prokinetic Drug Market Segment Percentages, by Type, 2021 (%)
Metoclopramide
Domperidone
Cisapride
Others
Global Prokinetic Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prokinetic Drug Market Segment Percentages, by Application, 2021 (%)
Gastroparesis
Constipation
Reflux Esophagitis
Functional Dyspepsia
Global Prokinetic Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Prokinetic Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prokinetic Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Prokinetic Drug revenues share in global market, 2021 (%)
Key companies Prokinetic Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Prokinetic Drug sales share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Sumitomo
Johnson & Johnson
Sanofi
Kyowa Kirin Pharmaceuticals
Pfizer
Teva
Cadila Pharmaceuticals
Hanmi Pharm
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Prokinetic Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prokinetic Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prokinetic Drug Overall Market Size
2.1 Global Prokinetic Drug Market Size: 2021 VS 2028
2.2 Global Prokinetic Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Prokinetic Drug Sales: 2017-2028
3 Company Landscape
3.1 Top Prokinetic Drug Players in Global Market
3.2 Top Global Prokinetic Drug Companies Ranked by Revenue
3.3 Global Prokinetic Drug Revenue by Companies
3.4 Global Prokinetic Drug Sales by Companies
3.5 Global Prokinetic Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Prokinetic Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Prokinetic Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prokinetic Drug Players in Global Market
3.8.1 List of Global Tier 1 Prokinetic Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Prokinetic Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Prokinetic Drug Market Size Markets, 2021 & 2028
4.1.2 Metoclopramide
4.1.3 Domperidone
4.1.4 Cisapride
4.1.5 Others
4.2 By Type - Global Prokinetic Drug Revenue & Forecasts
4.2.1 By Type - Global Prokinetic Drug Revenue, 2017-2022
4.2.2 By Type - Global Prokinetic Drug Revenue, 2023-2028
4.2.3 By Type - Global Prokinetic Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Prokinetic Drug Sales & Forecasts
4.3.1 By Type - Global Prokinetic Drug Sales, 2017-2022
4.3.2 By Type - Global Prokinetic Drug Sales, 2023-2028
4.3.3 By Type - Global Prokinetic Drug Sales Market Share, 2017-2028
4.4 By Type - Global Prokinetic Drug Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Prokinetic Drug Market Size, 2021 & 2028
5.1.2 Gastroparesis
5.1.3 Constipation
5.1.4 Reflux Esophagitis
5.1.5 Functional Dyspepsia
5.2 By Application - Global Prokinetic Drug Revenue & Forecasts
5.2.1 By Application - Global Prokinetic Drug Revenue, 2017-2022
5.2.2 By Application - Global Prokinetic Drug Revenue, 2023-2028
5.2.3 By Application - Global Prokinetic Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Prokinetic Drug Sales & Forecasts
5.3.1 By Application - Global Prokinetic Drug Sales, 2017-2022
5.3.2 By Application - Global Prokinetic Drug Sales, 2023-2028
5.3.3 By Application - Global Prokinetic Drug Sales Market Share, 2017-2028
5.4 By Application - Global Prokinetic Drug Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Prokinetic Drug Market Size, 2021 & 2028
6.2 By Region - Global Prokinetic Drug Revenue & Forecasts
6.2.1 By Region - Global Prokinetic Drug Revenue, 2017-2022
6.2.2 By Region - Global Prokinetic Drug Revenue, 2023-2028
6.2.3 By Region - Global Prokinetic Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Prokinetic Drug Sales & Forecasts
6.3.1 By Region - Global Prokinetic Drug Sales, 2017-2022
6.3.2 By Region - Global Prokinetic Drug Sales, 2023-2028
6.3.3 By Region - Global Prokinetic Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Prokinetic Drug Revenue, 2017-2028
6.4.2 By Country - North America Prokinetic Drug Sales, 2017-2028
6.4.3 US Prokinetic Drug Market Size, 2017-2028
6.4.4 Canada Prokinetic Drug Market Size, 2017-2028
6.4.5 Mexico Prokinetic Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Prokinetic Drug Revenue, 2017-2028
6.5.2 By Country - Europe Prokinetic Drug Sales, 2017-2028
6.5.3 Germany Prokinetic Drug Market Size, 2017-2028
6.5.4 France Prokinetic Drug Market Size, 2017-2028
6.5.5 U.K. Prokinetic Drug Market Size, 2017-2028
6.5.6 Italy Prokinetic Drug Market Size, 2017-2028
6.5.7 Russia Prokinetic Drug Market Size, 2017-2028
6.5.8 Nordic Countries Prokinetic Drug Market Size, 2017-2028
6.5.9 Benelux Prokinetic Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Prokinetic Drug Revenue, 2017-2028
6.6.2 By Region - Asia Prokinetic Drug Sales, 2017-2028
6.6.3 China Prokinetic Drug Market Size, 2017-2028
6.6.4 Japan Prokinetic Drug Market Size, 2017-2028
6.6.5 South Korea Prokinetic Drug Market Size, 2017-2028
6.6.6 Southeast Asia Prokinetic Drug Market Size, 2017-2028
6.6.7 India Prokinetic Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Prokinetic Drug Revenue, 2017-2028
6.7.2 By Country - South America Prokinetic Drug Sales, 2017-2028
6.7.3 Brazil Prokinetic Drug Market Size, 2017-2028
6.7.4 Argentina Prokinetic Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Prokinetic Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Prokinetic Drug Sales, 2017-2028
6.8.3 Turkey Prokinetic Drug Market Size, 2017-2028
6.8.4 Israel Prokinetic Drug Market Size, 2017-2028
6.8.5 Saudi Arabia Prokinetic Drug Market Size, 2017-2028
6.8.6 UAE Prokinetic Drug Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Sumitomo
7.1.1 Sumitomo Corporate Summary
7.1.2 Sumitomo Business Overview
7.1.3 Sumitomo Prokinetic Drug Major Product Offerings
7.1.4 Sumitomo Prokinetic Drug Sales and Revenue in Global (2017-2022)
7.1.5 Sumitomo Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Prokinetic Drug Major Product Offerings
7.2.4 Johnson & Johnson Prokinetic Drug Sales and Revenue in Global (2017-2022)
7.2.5 Johnson & Johnson Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Prokinetic Drug Major Product Offerings
7.3.4 Sanofi Prokinetic Drug Sales and Revenue in Global (2017-2022)
7.3.5 Sanofi Key News
7.4 Kyowa Kirin Pharmaceuticals
7.4.1 Kyowa Kirin Pharmaceuticals Corporate Summary
7.4.2 Kyowa Kirin Pharmaceuticals Business Overview
7.4.3 Kyowa Kirin Pharmaceuticals Prokinetic Drug Major Product Offerings
7.4.4 Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales and Revenue in Global (2017-2022)
7.4.5 Kyowa Kirin Pharmaceuticals Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Prokinetic Drug Major Product Offerings
7.5.4 Pfizer Prokinetic Drug Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Key News
7.6 Teva
7.6.1 Teva Corporate Summary
7.6.2 Teva Business Overview
7.6.3 Teva Prokinetic Drug Major Product Offerings
7.6.4 Teva Prokinetic Drug Sales and Revenue in Global (2017-2022)
7.6.5 Teva Key News
7.7 Cadila Pharmaceuticals
7.7.1 Cadila Pharmaceuticals Corporate Summary
7.7.2 Cadila Pharmaceuticals Business Overview
7.7.3 Cadila Pharmaceuticals Prokinetic Drug Major Product Offerings
7.7.4 Cadila Pharmaceuticals Prokinetic Drug Sales and Revenue in Global (2017-2022)
7.7.5 Cadila Pharmaceuticals Key News
7.8 Hanmi Pharm
7.8.1 Hanmi Pharm Corporate Summary
7.8.2 Hanmi Pharm Business Overview
7.8.3 Hanmi Pharm Prokinetic Drug Major Product Offerings
7.8.4 Hanmi Pharm Prokinetic Drug Sales and Revenue in Global (2017-2022)
7.8.5 Hanmi Pharm Key News
8 Global Prokinetic Drug Production Capacity, Analysis
8.1 Global Prokinetic Drug Production Capacity, 2017-2028
8.2 Prokinetic Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Prokinetic Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prokinetic Drug Supply Chain Analysis
10.1 Prokinetic Drug Industry Value Chain
10.2 Prokinetic Drug Upstream Market
10.3 Prokinetic Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prokinetic Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Prokinetic Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|